gabapentin 200 MG Oral Capsule

RxCUI
2739001
RxNorm name
gabapentin 200 MG Oral Capsule
Display name
gabapentin 200 MG Oral Capsule
Full name
gabapentin 200 MG Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:57

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GABAPENTINGABAPENTINPangea Pharmaceuticals, LLC5eff7ad8-0d31-4372-82a2-ac9f549d87962026-05-22Warnings, Adverse reactionsExact identifier
rxcui: 2739001
RELGAABIGABAPENTINMethod Pharmaceuticals, LLC4cc6615b-5447-9c0e-e063-6394a90a28832026-04-08Warnings, Adverse reactionsExact identifier
rxcui: 2739001

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4cc6615b-5447-9c0e-e063-6394a90a2883gabapentin 200 MG Oral Capsule [PSN] · gabapentin 200 MG Oral Capsule [SCD] · gabapentin 200 MG Oral Capsule [SY]32These highlights do not include all the information needed to use RELGAABI safely and effectively. See full prescribing information for RELGAABI. RELGAABI (gabapentin) capsules, for oral use Initial U.S. Approval: 199320260408
5eff7ad8-0d31-4372-82a2-ac9f549d8796gabapentin 200 MG Oral Capsule [PSN] · gabapentin 200 MG Oral Capsule [SCD] · gabapentin 200 MG Oral Capsule [SY]31These highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 199320260522